Evidence map›Paper›PMID 27774350›Full record

ArticleJournal of AIDS & clinical research2015

The Art of HIV Elimination: Past and Present Science.

Collins C Iwuji, Nuala McGrath, Tulio de Oliveira, Kholoud Porter, Deenan Pillay, Martin Fisher, Melanie Newport, Marie-Louise Newell

Open access · hybridAbstract read
In one paragraph

Article in Journal of AIDS & clinical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Continuing Links Between Substance Use and HIV Highlight the Importance of Nursing Roles.The Journal of the Association of Nurses in AIDS Care : JANAC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Collins C IwujiAfrica Centre for Health and Population Studies, University of KwaZulu Natal, South Africa; Research Department of Infection and Population Health, University College London, UK.
Nuala McGrathAfrica Centre for Health and Population Studies, University of KwaZulu Natal, South Africa; Academic Unit of Primary Care and Population Sciences, and Department of Social statistics and Demography, University of Southampton, UK.
Tulio de OliveiraAfrica Centre for Health and Population Studies, University of KwaZulu Natal, South Africa.
Kholoud PorterMRC Clinical Trials Unit at UCL, London, UK.
Deenan PillayAfrica Centre for Health and Population Studies, University of KwaZulu Natal, South Africa; Research Department of Infection and Immunity, University College London, UK.
Martin FisherDivision of Medicine, Brighton and Sussex Medical School, UK.
Melanie NewportDepartment of Infectious Diseases and Global Health, Brighton and Sussex Medical School, UK.
Marie-Louise NewellFaculty of Medicine and Faculty of Social and Human Sciences, University of Southampton, UK.
University of KwaZulu-Natal · ZAUniversity of Southampton · GB

Funding

Medical Research Council MC_UU_12023/15Wellcome Trust 097410
6 · The paper itself

Abstract

introductionRemarkable strides have been made in controlling the HIV epidemic, although not enough to achieve epidemic control. More recently, interest in biomedical HIV control approaches has increased, but substantial challenges with the HIV cascade of care hinder successful implementation. We summarise all available HIV prevention methods and make recommendations on how to address current challenges. DISCUSSION: In the early days of the epidemic, behavioural approaches to control the HIV dominated, and the few available evidence-based interventions demonstrated to reduce HIV transmission were applied independently from one another. More recently, it has become clear that combination prevention strategies targeted to high transmission geographies and people at most risk of infections are required to achieve epidemic control. Biomedical strategies such as male medical circumcision and antiretroviral therapy for treatment in HIV-positive individuals and as pre-exposure prophylaxis in HIV-negative individuals provide immense promise for the future of HIV control. In resource-rich settings, the threat of HIV treatment optimism resulting in increased sexual risk taking has been observed and there are concerns that as ART roll-out matures in resource-poor settings and the benefits of ART become clearly visible, behavioural disinhibition may also become a challenge in those settings. Unfortunately, an efficacious vaccine, a strategy which could potentially halt the HIV epidemic, remains elusive.

conclusionCombination HIV prevention offers a logical approach to HIV control, although what and how the available options should be combined is contextual. Therefore, knowledge of the local or national drivers of HIV infection is paramount. Problems with the HIV care continuum remain of concern, hindering progress towards the UNAIDS target of 90-90-90 by 2020. Research is needed on combination interventions that address all the steps of the cascade as the steps are not independent of each other. Until these issues are addressed, HIV elimination may remain an unattainable goal.

Indexed as

Antiretroviral therapyCombination HIV preventionHIVHIV cascadeHIV vaccinesPost-exposure prophylaxisPre-exposure prophylaxis

Identifiers

PMID27774350
PMCPMC5072486
OpenAlexW2294238943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.